ArticleSystematic reviews2025
Factors influencing early detection of lung cancer in patients in low- and middle-income countries: a scoping review protocol.
Article in Systematic reviews, 2025. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Not yet cited in PubMed.
What it found
Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.
The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.
The trial behind it
Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.
Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.
Who cites it
0 citing papers in PubMed.
No citing paper in PubMed yet.
Corrections and comments
PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.
Authors and funding
4 authors.
Funding
No grant is acknowledged in the PubMed record.
Abstract
introductionCancer is a leading cause of mortality globally. It is increasingly becoming a public health concern in sub-Saharan Africa (SSA) and a major societal and economic problem worldwide. Approximately three quarters of all cancer-related deaths occur in low- and middle-income countries (LMICs), with lung cancer being the most frequently diagnosed cancer in 2022. Given the poor health outcomes associated with late diagnosis, early detection for lung cancer should be prioritised to rekindle hope for improved health outcomes. This is a scoping review protocol paper aimed at mapping evidence on factors influencing early identification of lung cancer in patients in low- and middle-income countries. METHODS AND ANALYSIS: In conducting the proposed scoping review, we will follow the methodological framework proposed by Arksey and O'Malley and recommendations by Levac et al. We will also be guided by the Preferred Reporting Items for Systematic Reviews and Meta-Analyses Extension for scoping reviews (PRISMA-ScR): checklist and explanation. The following electronic databases will be searched: PubMed, Cochrane Library, Scopus, CINAHL, EMBASE, and Google Scholar. The following grey literature sources will be searched: conference proceedings, other relevant government reports, and dissertations/thesis. Key themes from the literature will be extracted and analysed using thematic analysis supported by NVivo version 14. Evidence gathered will be used towards advocating for early screening of patients suspected of lung cancer. ETHICS AND DISSEMINATION: This review is exempt from ethical approval as it uses data that is in the public domain. Additionally, there will be no human or animal participants in this review; hence, informed consent is not required. The results will be published in peer-reviewed journals, in print, and through conference presentations. SYSTEMATIC REVIEW REGISTRATION: https://doi.org/10.17605/OSF.IO/ZQEXT.
Indexed as
Identifiers
What OpenQuestion holds
Registered trials
Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.